WHO ICTRP trial
The effect of the secondary bile acid glycodeoxycholic acid as a therapy for…
NL-OMON20316 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON20316 |
|---|---|
| Public title | The effect of the secondary bile acid glycodeoxycholic acid as a therapy for diabetes. |
| Scientific title | Targeting the secondary bile acid glycodeoxycholic acid as therapeutic strategy in type 2 diabetes mellitus. |
| Primary sponsor | Academic Medical Center (AMC), Amsterdam, The Nettherlands |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | type 2 diabetes mellitus |
| Interventions | In phase 1, the healthy subjects will be randomized into 2 groups. The first group (N=10) will receive 10 mg/kg/day gDCA for 30 days, the other group (N=10) will receive 10 mg/kg/day enteric coated gDCA for 30 days. The first 5 healthy… |
| Registration date | Sep 26, 2017 |
| Target size | 40 |
| Secondary IDs | NL6526;NTR6714;NL.61855.018.17 : METC2017_133 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: